Physician

Jeffrey Ogbara, MD

According to 2025 Medicare claims, Jeffrey Ogbara, MD (NPI: 1528112513) practices interventional cardiology in the Vineland, NJ market, with the plurality of this provider's patient population coming from Cumberland, NJ. This provider's primary affiliated billing organization is CARDIOVASCULAR ASSOCIATES OF THE DELAWARE VALLEY,P A (NPI: 1366495632; TIN: 223321233) and primary practice location at 08103-1461.

Ogbara's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 925 traditional Medicare patients, billed 2,944 HCPCS/CPT codes, and received $214,663 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,895 prescription claims across 382 beneficiaries totaling $412,542 in drug costs, led by Eliquis (Apixaban). 2019 DME data shows 29 claims. Open Payments data shows 75 records totaling $4,813. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $31,069 to $412,542. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $71,221 to $9,038.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,828	3,568	$264,109
2016	1,720	3,283	$234,810
2017	1,895	3,673	$236,482
2018	1,523	3,190	$218,933
2019	1,123	2,642	$219,185
2020	1,225	2,555	$194,786
2021	980	2,495	$218,463
2022	894	2,202	$198,926
2023	746	2,338	$214,486
2024	925	2,944	$214,663

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	143	874	$31,069
2016	222	1,029	$82,985
2017	207	1,114	$120,972
2018	212	1,022	$109,742
2019	217	1,195	$168,161
2020	231	1,191	$183,892
2021	228	1,174	$222,949
2022	258	1,274	$264,588
2023	272	1,312	$322,112
2024	382	1,895	$412,542

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	16	34	$71,221
2016	15	41	$82,195
2017	13	27	$52,694
2018	13	27	$57,152
2019	12	29	$64,496
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	309	439	$103
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	186	304	$67
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	163	205	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	378	533	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	158	191	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	112	7,109	$136,879
Entresto	Sacubitril/Valsartan	96	5,686	$124,212
Brilinta	Ticagrelor	29	2,260	$32,253
Farxiga	Dapagliflozin Propanediol	31	1,710	$28,203
Xarelto	Rivaroxaban	21	1,470	$26,258

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	75	$4,813	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jeffrey Ogbara, MD?

Tedicare shows public-source Medicare data for Jeffrey Ogbara, MD (NPI 1528112513), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey Ogbara, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jeffrey Ogbara, MD?

Jeffrey Ogbara, MD is linked to CARDIOVASCULAR ASSOCIATES OF THE DELAWARE VALLEY,P A (billing NPI 1366495632) in the available physician profile data.

Does Jeffrey Ogbara, MD have Open Payments data?

Jeffrey Ogbara, MD has 75 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.